Premium
Bulk-drugs manufacturer ZCL Chemicals Ltd, which had initiated talks last year to provide Morgan Stanley Private Equity Asia with an exit, has attracted bids from four groups for its proposed sale, two people privy to the development told VCCircle. Players including American PE firm Advent International, Singapore- and India-based healthcare-focused PE ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
